Differently from anemia, which was a strong predictor for both early and late mortality in patients with severe aortic stenosis undergoing TAVR, high baseline EPO levels were an independent biomarker for mid-term mortality, with its prognostic value only emerging after post-TAVR recovery was completed. Here, EPO is linked to aortic stenosis.